- Home
- CPRX vs TBBK Comparison
CPRX vs TBBK Comparison
Compare CPRX & TBBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRX
- TBBK
- Stock Information
- Founded
- CPRX 2002
- TBBK 1999
- Country
- CPRX United States
- TBBK United States
- Employees
- CPRX N/A
- TBBK N/A
- Industry
- CPRX Biotechnology: Pharmaceutical Preparations
- TBBK Major Banks
- Sector
- CPRX Health Care
- TBBK Finance
- Exchange
- CPRX Nasdaq
- TBBK Nasdaq
- Market Cap
- CPRX 2.5B
- TBBK 2.7B
- IPO Year
- CPRX 2006
- TBBK 2004
- Fundamental
- Price
- CPRX $22.34
- TBBK $55.69
- Analyst Decision
- CPRX Strong Buy
- TBBK Buy
- Analyst Count
- CPRX 7
- TBBK 3
- Target Price
- CPRX $31.14
- TBBK $55.00
- AVG Volume (30 Days)
- CPRX 820.3K
- TBBK 405.3K
- Earning Date
- CPRX 11-06-2024
- TBBK 01-23-2025
- Dividend Yield
- CPRX N/A
- TBBK N/A
- EPS Growth
- CPRX 114.68
- TBBK 16.50
- EPS
- CPRX 1.18
- TBBK 3.95
- Revenue
- CPRX $460,482,000.00
- TBBK $472,068,000.00
- Revenue This Year
- CPRX $23.98
- TBBK N/A
- Revenue Next Year
- CPRX $18.27
- TBBK $7.93
- P/E Ratio
- CPRX $18.72
- TBBK $14.13
- Revenue Growth
- CPRX 32.17
- TBBK 6.73
- 52 Week Low
- CPRX $13.12
- TBBK $29.92
- 52 Week High
- CPRX $24.27
- TBBK $61.17
- Technical
- Relative Strength Index (RSI)
- CPRX 54.94
- TBBK 49.96
- Support Level
- CPRX $20.93
- TBBK $55.25
- Resistance Level
- CPRX $22.49
- TBBK $57.38
- Average True Range (ATR)
- CPRX 0.60
- TBBK 1.68
- MACD
- CPRX 0.00
- TBBK -0.28
- Stochastic Oscillator
- CPRX 77.06
- TBBK 20.75
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.
About TBBK The Bancorp Inc
The Bancorp Inc is a financial holding company, through its subsidiary it is engaged in specialty lending namely securities-backed lines of credit, vehicle fleet and another equipment leasing, Small Business Administration lending, insurance policy cash value-backed lines of credit and commercial mortgage-backed loans, generated for sale into commercial mortgage-backed securities markets through securitizations. The company deposits and non-interest income are generated in the payments business which consists of issuing, acquiring, and automated clearing house accounts.